- Home
- BEDU vs DXR Comparison
BEDU vs DXR Comparison
Compare BEDU & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- DXR
- Stock Information
- Founded
- BEDU 1994
- DXR 1970
- Country
- BEDU United Kingdom
- DXR United States
- Employees
- BEDU N/A
- DXR N/A
- Industry
- BEDU Other Consumer Services
- DXR Medical/Dental Instruments
- Sector
- BEDU Real Estate
- DXR Health Care
- Exchange
- BEDU Nasdaq
- DXR Nasdaq
- Market Cap
- BEDU 54.0M
- DXR 46.9M
- IPO Year
- BEDU 2017
- DXR N/A
- Fundamental
- Price
- BEDU $1.67
- DXR $10.72
- Analyst Decision
- BEDU
- DXR Strong Buy
- Analyst Count
- BEDU 0
- DXR 1
- Target Price
- BEDU N/A
- DXR $25.00
- AVG Volume (30 Days)
- BEDU 867.0
- DXR 78.2K
- Earning Date
- BEDU 09-02-2025
- DXR 01-01-0001
- Dividend Yield
- BEDU N/A
- DXR N/A
- EPS Growth
- BEDU N/A
- DXR 86.16
- EPS
- BEDU N/A
- DXR 0.11
- Revenue
- BEDU $224,321,752.00
- DXR $119,714.00
- Revenue This Year
- BEDU N/A
- DXR N/A
- Revenue Next Year
- BEDU N/A
- DXR N/A
- P/E Ratio
- BEDU N/A
- DXR $101.38
- Revenue Growth
- BEDU N/A
- DXR N/A
- 52 Week Low
- BEDU $1.35
- DXR $6.55
- 52 Week High
- BEDU $2.19
- DXR $11.38
- Technical
- Relative Strength Index (RSI)
- BEDU 38.34
- DXR 57.46
- Support Level
- BEDU $1.65
- DXR $10.01
- Resistance Level
- BEDU $1.91
- DXR $11.02
- Average True Range (ATR)
- BEDU 0.01
- DXR 0.70
- MACD
- BEDU -0.00
- DXR 0.05
- Stochastic Oscillator
- BEDU 22.22
- DXR 67.14
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.